Checklist: Utilization of the newly insured
With increased coverage under the Patient Protection and Affordable Care Act (PPACA), insurers are expecting an influx of enrollees.
With increased coverage under the Patient Protection and Affordable Care Act (PPACA), insurers are expecting an influx of enrollees. One study shows there is no such thing as an average patient, and comparisons can be misleading.
A recent study from the IMS Institute of Healthcare Informatics indicates that using Medicare as a template-which is often the case in policy research-is too "one size fits all" when compared to the privately insured, under-65 population. A glance at the ratio of outpatient to inpatient expenditures for both populations confirms this.
The report concludes that there is no such thing as an average patient. Using Medicare as a template will only make insurers unable to provide quality healthcare packages and optimal services.
Most Patients With HS Aren’t Aware of Approved Treatments
May 1st 2025Treating hidradenitis suppurativa is complex and often requires taking a number of medications, including antibiotics, hormone therapies and immunosuppressants. However, many of these treatments are used off-label, and at this time, only two biologic therapies—Humira (adalimumab) and Cosentyx (secukinumab)— are approved by the FDA for HS treatment.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
